Cytokine Secretion via Cholesterol-rich Lipid Raft-associated SNAREs at the Phagocytic Cup*
暂无分享,去创建一个
J. Pagan | J. Stow | J. Kay | R. Z. Murray
[1] J. Stow,et al. A Role for the Phagosome in Cytokine Secretion , 2005, Science.
[2] D. Predescu,et al. Cholesterol-dependent Syntaxin-4 and SNAP-23 Clustering Regulates Caveolar Fusion with the Endothelial Plasma Membrane* , 2005, Journal of Biological Chemistry.
[3] K. Gaus,et al. Condensation of the plasma membrane at the site of T lymphocyte activation , 2005, The Journal of cell biology.
[4] K. Gaus,et al. Domain-specific lipid distribution in macrophage plasma membranes Published, JLR Papers in Press, May 1, 2005. DOI 10.1194/jlr.M500103-JLR200 , 2005, Journal of Lipid Research.
[5] W. Hong. SNAREs and traffic. , 2005, Biochimica et biophysica acta.
[6] G. Gould,et al. Lipid Raft Association of SNARE Proteins Regulates Exocytosis in PC12 Cells* , 2005, Journal of Biological Chemistry.
[7] Alex Soler-Jover,et al. Synaptic proteins and SNARE complexes are localized in lipid rafts from rat brain synaptosomes. , 2005, Biochemical and biophysical research communications.
[8] D. Hume,et al. Syntaxin 6 and Vti1b Form a Novel SNARE Complex, Which Is Up-regulated in Activated Macrophages to Facilitate Exocytosis of Tumor Necrosis Factor-α* , 2005, Journal of Biological Chemistry.
[9] J. Loike,et al. Statin Inhibition of Fc Receptor–Mediated Phagocytosis by Macrophages Is Modulated by Cell Activation and Cholesterol , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[10] A. Muntasell,et al. MHC Class II Molecules Traffic into Lipid Rafts during Intracellular Transport , 2004, The Journal of Immunology.
[11] J. Cuschieri. Implications of lipid raft disintegration: enhanced anti-inflammatory macrophage phenotype. , 2004, Surgery.
[12] Elizabeth S. Gold,et al. Simvastatin Augments Lipopolysaccharide-Induced Proinflammatory Responses in Macrophages by Differential Regulation of the c-Fos and c-Jun Transcription Factors1 , 2004, The Journal of Immunology.
[13] T. Harder,et al. Membrane Domains in Lymphocytes – From Lipid Rafts to Protein Scaffolds , 2004, Traffic.
[14] L. Chamberlain,et al. Lipid Rafts and the Regulation of Exocytosis , 2004, Traffic.
[15] P. Borchmann,et al. Depletion of Cellular Cholesterol and Lipid Rafts Increases Shedding of CD301 , 2004, The Journal of Immunology.
[16] Robert G Parton,et al. Lipid rafts and plasma membrane microorganization: insights from Ras. , 2004, Trends in cell biology.
[17] A. Laude,et al. Plasma membrane microdomains: Organization, function and trafficking (Review) , 2004 .
[18] E. Gratton,et al. Visualizing lipid structure and raft domains in living cells with two-photon microscopy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. Kunapuli,et al. Membrane lipid microdomains differentially regulate intracellular signaling events in human neutrophils. , 2003, International immunopharmacology.
[20] Shiang-Jong Tzeng,et al. Location is everything: lipid rafts and immune cell signaling. , 2003, Annual review of immunology.
[21] J. Rivera,et al. Munc18‐2/syntaxin3 complexes are spatially separated from syntaxin3‐containing SNARE complexes , 2003, FEBS letters.
[22] Dongxu Sun,et al. Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proinflammatory cytokine production. , 2003, Cellular immunology.
[23] M. Verhage,et al. Vesicle trafficking: pleasure and pain from SM genes. , 2003, Trends in cell biology.
[24] D. Richards,et al. Monocyte lipid rafts contain proteins implicated in vesicular trafficking and phagosome formation , 2003, Proteomics.
[25] M. Endres,et al. Treatment of Relapsing Paralysis in Experimental Encephalomyelitis by Targeting Th1 Cells through Atorvastatin , 2003, The Journal of experimental medicine.
[26] D. James,et al. The t-SNARE Syntaxin 4 Is Regulated during Macrophage Activation to Function in Membrane Traffic and Cytokine Secretion , 2003, Current Biology.
[27] G. Gould,et al. The Vesicle- and Target-SNARE Proteins That Mediate Glut4 Vesicle Fusion Are Localized in Detergent-insoluble Lipid Rafts Present on Distinct Intracellular Membranes* , 2002, The Journal of Biological Chemistry.
[28] D. James,et al. Flotillin-1/Reggie-2 Traffics to Surface Raft Domains via a Novel Golgi-independent Pathway , 2002, The Journal of Biological Chemistry.
[29] S. Youssef,et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease , 2002, Nature.
[30] F. Brodsky,et al. Lipid rafts unite signaling cascades with clathrin to regulate BCR internalization. , 2002, Immunity.
[31] D. Golenbock,et al. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. , 2002, Journal of cell science.
[32] David A. Hume,et al. Generation of Diversity in the Innate Immune System: Macrophage Heterogeneity Arises from Gene-Autonomous Transcriptional Probability of Individual Inducible Genes1 , 2002, The Journal of Immunology.
[33] R. Black,et al. Tumor necrosis factor-alpha converting enzyme. , 2002, The international journal of biochemistry & cell biology.
[34] Ruslan Medzhitov,et al. Toll-like receptors and innate immunity , 2001, Nature Reviews Immunology.
[35] G. Gould,et al. SNARE proteins are highly enriched in lipid rafts in PC12 cells: Implications for the spatial control of exocytosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[36] D. Bruns,et al. SNAREs are concentrated in cholesterol‐dependent clusters that define docking and fusion sites for exocytosis , 2001, The EMBO journal.
[37] Etienne Gagnon,et al. The Phagosome Proteome: Insight into Phagosome Functions , 2001 .
[38] M. Wolzt,et al. Similar Effects of Atorvastatin, Simvastatin and Pravastatin on Thrombogenic and Inflammatory Parameters in Patients with Hypercholesterolemia , 2001, Thrombosis and Haemostasis.
[39] P. M. Davis,et al. Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors. , 2001, International immunopharmacology.
[40] J. Pagan,et al. Endocytosis of Uncleaved Tumor Necrosis Factor-α in Macrophages , 2001, Laboratory Investigation.
[41] L. Foster,et al. Mechanism and regulation of GLUT-4 vesicle fusion in muscle and fat cells. , 2000, American journal of physiology. Cell physiology.
[42] P. Roche,et al. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation , 2000, Nature Immunology.
[43] J. Pieters,et al. Essential role for cholesterol in entry of mycobacteria into macrophages. , 2000, Science.
[44] S. Grinstein,et al. Focal Exocytosis of Vamp3-Containing Vesicles at Sites of Phagosome Formation , 2000, The Journal of cell biology.
[45] A. Ridley,et al. Lipopolysaccharide Induces Actin Reorganization and Tyrosine Phosphorylation of Pyk2 and Paxillin in Monocytes and Macrophages1 , 2000, The Journal of Immunology.
[46] D. Hume,et al. Localization and post-Golgi trafficking of tumor necrosis factor-alpha in macrophages. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[47] R. Mitchell,et al. A Role for Lipid Rafts in B Cell Antigen Receptor Signaling and Antigen Targeting , 1999, The Journal of experimental medicine.
[48] M. Resh. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. , 1999, Biochimica et biophysica acta.
[49] F. Wylie,et al. GAIP, a Gαi-3-binding protein, is associated with Golgi-derived vesicles and protein trafficking. , 1999, American journal of physiology. Cell physiology.
[50] A. Lanzavecchia,et al. T lymphocyte costimulation mediated by reorganization of membrane microdomains. , 1999, Science.
[51] A. Hall,et al. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. , 1998, Science.
[52] M. Bukrinsky,et al. Relative Contribution of Transcription and Translation to the Induction of Tumor Necrosis Factor-α by Lipopolysaccharide* , 1998, The Journal of Biological Chemistry.
[53] R. Parton,et al. Regulation of caveolin and caveolae by cholesterol in MDCK cells. , 1997, Journal of lipid research.
[54] A. Namboodiri,et al. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. , 1997, The Journal of clinical investigation.
[55] G. Bokoch,et al. Requirements for Both Rac1 and Cdc42 in Membrane Ruffling and Phagocytosis in Leukocytes , 1997, The Journal of experimental medicine.
[56] M C Phillips,et al. Use of cyclodextrins for manipulating cellular cholesterol content. , 1997, Journal of lipid research.
[57] H. Lodish,et al. Flotillin and Epidermal Surface Antigen Define a New Family of Caveolae-associated Integral Membrane Proteins* , 1997, The Journal of Biological Chemistry.
[58] M. Kasuga,et al. Inhibition of the binding of SNAP-23 to syntaxin 4 by Munc18c. , 1997, Biochemical and biophysical research communications.
[59] Nicole Nelson,et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.
[60] B. Baird,et al. Compartmentalized Activation of the High Affinity Immunoglobulin E Receptor within Membrane Domains* , 1997, The Journal of Biological Chemistry.
[61] S. Grinstein,et al. Characterization and subcellular localization of target membrane soluble NSF attachment protein receptors (t-SNAREs) in macrophages. Syntaxins 2, 3, and 4 are present on phagosomal membranes. , 1996, Journal of immunology.
[62] George Kollias,et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor , 1995, Cell.
[63] P. Vandenabeele,et al. Generation and Biological Characterization of Membrane-bound, Uncleavable Murine Tumor Necrosis Factor (*) , 1995, The Journal of Biological Chemistry.
[64] Deborah A. Brown,et al. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface , 1992, Cell.
[65] W. Fiers. Tumor necrosis factor Characterization at the molecular, cellular and in vivo level , 1991, FEBS letters.
[66] L. Gooding,et al. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact , 1990, Cell.